ArticleAmerican journal of clinical oncology2008
Competing causes of death for women with breast cancer and change over time from 1975 to 2003.
Article in American journal of clinical oncology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
35 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.
- Protective role of beta-blockers in chemotherapy-induced cardiotoxicity-a systematic review and meta-analysis of carvedilol.Heart failure reviews · 2019Pooled it
- Heart failure related cardiotoxicity in breast cancer survivors: a scoping review.Cardio-oncology (London, England) · 2025Review
- Limited Chemopreventive Effects of Oral Administration of Polyphenol-60 from Green Tea in the MNU-Induced Rat Mammary Tumor Model.Antioxidants (Basel, Switzerland) · 2025Article
- Androgen Receptors in Human Breast Cancer and Female Canine Mammary Tumors.Molecules (Basel, Switzerland) · 2025Review
- Impact of Anti-Estrogen Therapy on Early Cardiovascular Referrals, Tests and Medications in Premenopausal Women with Operable Breast Cancer.Clinical breast cancer · 2024Article
- Cardiovascular impact of near complete estrogen deprivation in premenopausal women with breast cancer: The CROWN study.American heart journal · 2024Article
- Age-Dependent Causes of Death among Patients with Breast Cancer Based on Osaka Cancer Registry and Vital Statistics in Japan.Healthcare (Basel, Switzerland) · 2023Article
- Cause of Death among Long-Term Cancer Survivors: The NANDE Study.Healthcare (Basel, Switzerland) · 2023Article
- County-level geographic disparities in cardiovascular disease mortality among US breast cancer survivors, 2000-2018.JNCI cancer spectrum · 2023Article
- Hormonal Homologies between Canine Mammary Cancer and Human Breast Cancer in a Series of Cases.Veterinary sciences · 2022Article
- Age and competing concerns in treatment selection for women with non-metastatic HR+ and HER2- breast cancer: Current clinical practice.Journal of geriatric oncology · 2022Article
- Association between age at initial diagnosis and post-metastasis mortality among women with recurrent metastatic breast cancer in China.BMC cancer · 2022Article
- Trends in heart disease mortality among breast cancer survivors in the US, 1975-2017.Breast cancer research and treatment · 2022Article
- Does Cardiovascular Mortality Overtake Cancer Mortality During Cancer Survivorship?: An English Retrospective Cohort Study.JACC. CardioOncology · 2022Article
- Mortgage Lending Bias and Breast Cancer Survival Among Older Women in the United States.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2021Article
- Article
- Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2021Review
- The Wnt Signalling Pathway: A Tailored Target in Cancer.International journal of molecular sciences · 2020Review
- Adjuvant chemotherapy-associated lipid changes in breast cancer patients: A real-word retrospective analysis.Medicine · 2020Article
- Mycogenic Synthesis of Extracellular Zinc Oxide Nanoparticles fromInternational journal of nanomedicine · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
This study was to determine whether the proportion of death due to breast cancer changed over time in different cohorts of women diagnosed with breast cancer. We identified 316,149 women with breast cancer at age 20 or older during 1975-2003 from the Surveillance, Epidemiology, and End Results 9 tumor registries in the United States. Logistic regression models were used to assess the effects of time period on the likelihood of dying because of breast cancer as underlying cause of death, adjusting for other factors. Overall, underlying cause of death was 52.8% due to breast cancer, 17.8% due to heart disease, and 4.9% due to stroke. Percentage of death due to breast cancer did not change significantly from 1975 to 2003 in those who died < 12 months after diagnosis, but decreased significantly in women who died between 1 and 15 years. Risk of death due to breast cancer in women diagnosed during 1995-1998 was significantly lower than those in 1975-1979 (odds ratio = 0.79, 95% confidence interval = 0.70-0.89), after adjusting for age, race, ethnicity, and tumor stage. Percentage of death due to breast cancer decreased significantly with age from 87.5% in women < 40% to 30.7% in those 80 or older, which was not significantly affected by year of diagnosis. Proportion of death due to breast cancer increased with advanced tumor stage and was similar in various racial/ethnic groups of population. The findings demonstrated that the impact of breast cancer on overall death was reduced after 1 year of diagnosis, but suggested the need for continued cancer surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.